Further, our in vivo data indicate that Mecp2 null cerebella are characterized by reduced levels of Gli1 and a defective expression of other members of the same pathway, opening up new perspectives for the comprehension of the pathogenic mechanisms contributing to RTT and their treatment. This evidence concerns the gene MECP2 and Rett syndrome.